EGM
MLNT

Engineers Gate Manager’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Engineers Gate Manager’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,231
Closed -$157K – 1271
2018
Q1 		$157K Buy
+4,231
New +$278K 0.01% 747

Other funds holding MLNT

OH
Oikos Holdings New York $422M AUM 13.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Engineers Gate Manager's MLNT Position: Q2 2018 in Review

Engineers Gate Manager sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q2 2018, closing a stake of 4,231 shares — an estimated $157K sold.

Engineers Gate Manager first reported a position in MLNT in Q1 2018 and held it in 1 quarter. The position peaked at $157K in Q1 2018. 87 funds tracked by Wall St. Rank hold MLNT as of Q2 2018.

  • Engineers Gate Manager reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Engineers Gate Manager sold 4,231 Melinta Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $157K.
  • Engineers Gate Manager first reported a position in Melinta Therapeutics, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Engineers Gate Manager's Melinta Therapeutics, Inc. Common Stock position peaked at $157K in Q1 2018.
  • 87 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q2 2018.

Based on Engineers Gate Manager's 13F filing for Q2 2018, filed 3 Aug 2018.